4//SEC Filing
STUART LEWIS J 4
Accession 0001181431-09-020231
CIK 0000921506other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 1:25 PM ET
Size
7.9 KB
Accession
0001181431-09-020231
Insider Transaction Report
Form 4
STUART LEWIS J
SVP COMMERCIAL OPERATIONS
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2009-04-16$9.55/sh−88,542$845,576→ 0 totalExercise: $10.45From: 2007-09-22Exp: 2017-08-22→ Common Stock (88,542 underlying)
Holdings
- 5,786.414(indirect: By 401(k))
Common Stock
- 57,991
Common Stock
Footnotes (3)
- [F1]Includes 217 shares acquired April 14, 2009 pursuant to the CV Therapeutics, Inc. Employee Stock Purchase Plan ("ESPP").
- [F2]Shares held in the Reporting Person's name by the Issuer's 401(k) plan.
- [F3]This option to purchase shares of the Issuer's stock, which provided that 1/36th of the shares subject to the option grant shall vest on the 22nd day of each calendar month following the August 22, 2007 date of grant, became 100% vested and exercisable due to a change in control of the Issuer effected through the tender offer by Apex Merger Sub, Inc. ("Apex"), a wholly owned subsidiary of Gilead Sciences, Inc. ("Gilead), effective as of April 16, 2009. The Issuer will make a cash payment of $845,576.10, representing the gross cash amount, less applicable withholding, for the remaining shares subject to this option which became 100% vested and exercisable due to the change in control, to the Reporting Party.
Issuer
CV THERAPEUTICS INC
CIK 0000921506
Entity typeother
Related Parties
1- filerCIK 0001407368
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 1:25 PM ET
- Size
- 7.9 KB